Barely Significant
← all excerpts

Oral liarozole in the treatment of patients with moderate/severe lamellar ichthyosis: results of a randomized, double-blind, multinational, placebo-controlled phase II/III trial.

Br J Dermatol · 2014 · PMC4232915 · PMID 24102348

2
hedged sentences
closest p
boldest claim

The sentences

showed a trendno p-value reported
12 , 13 In the comparative study, liarozole was equally as effective as acitretin and showed a trend towards a more favourable tolerability profile. 13 The objective of this study was to demonstrate the efficacy and safety of once-daily oral liarozole, 75 or 150 mg, vs. placebo in the treatment of patients with moderate/severe lamellar ichthyosis.

also in 53,322 other papers

Conclusions The primary efficacy variable did not reach statistical significance, possibly owing to the small sample size following premature termination.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.